Jae Y. Ro

540 citations
10 papers · 394 indexed · h-index 9
Topics
Renal cell carcinoma treatment (3 papers)Renal and related cancers (3 papers)Cancer Genomics and Diagnostics (3 papers)
Partner nations
United StatesSouth Korea

In The Last Decade

Jae Y. Ro

10 papers receiving 378 citations

Peers

Jae Y. Ro
Comparison fields: 5 of 43
  • Pulmonary and Respiratory Medicine 259
  • Molecular Biology 147
  • Surgery 142
  • Oncology 110
  • Cancer Research 64
Replace Marc Ladanyi with:
Marc Ladanyi United States
Thomas Zaramboukas Greece
Shotaro Maeda Japan
Maria Stefania Lagonigro Italy
Mariola Iliszko Poland
Małgorzata Babińska Poland
Celia Mor Israel
Sverre Heim Sweden
Ken-ichi Kawaguchi Japan
Jan Åhlén Sweden
Jae Y. Ro relative to Marc Ladanyi United States Marc Ladanyi's profile →
Citations per field
00.5×1.7×
Marc Ladanyi · 1×
Citations per year

Countries citing papers authored by Jae Y. Ro

Since Specialization
Citations

This map shows the geographic impact of Jae Y. Ro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jae Y. Ro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jae Y. Ro more than expected).

Fields of papers citing papers by Jae Y. Ro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jae Y. Ro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jae Y. Ro. The network helps show where Jae Y. Ro may publish in the future.

Co-authorship network of co-authors of Jae Y. Ro

This figure shows the co-authorship network connecting the top 25 collaborators of Jae Y. Ro. A scholar is included among the top collaborators of Jae Y. Ro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jae Y. Ro. Jae Y. Ro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1
Clinicopathologic characteristics of replication error-positive gastric carcinoma.
30
2 52
3 53
4 29
5 26
6 73
7 36
8 49
9 3
10 43

About Jae Y. Ro

Jae Y. Ro is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Rheumatology, having authored 10 papers that have together received 394 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (3 papers), Renal and related cancers (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (259 citations), Cancer Research (64 citations) and Neurology (62 citations). Jae Y. Ro has collaborated with scholars based in United States and South Korea. Frequent co-authors include Alberto G. Ayala, Adel K. El-Naggar, Adel K. El‐Naggar, Donia McLemore, Alberto G. Ayala, Lisa G. Ensign, Fadi W. Abdul‐Karim, Lisa Garnsey, John G. Batsakis and Ángel Zavala-Pompa. Their work appears in journals such as Cancer, International Journal of Radiation Oncology*Biology*Physics and Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026